Inhaltsbereich
| 170 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9 › » |
Seite 1 / 9
 Druckansicht
|
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. |
| Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
| Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
| PMID: 26040499 |
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer. |
| Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R, Marth C |
| The New England journal of medicine. 2009 Feb 13. pii: 360/7/679. doi: 10.1056/NEJMoa0806285 |
| PMID: 19213681 |
| Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. |
| Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R |
| The Lancet. Oncology. 2008 Aug 19. pii: S1470-2045(08)70204-3. doi: 10.1016/S1470-2045(08)70204-3 |
| PMID: 18718815 |
| Increased expression of miR-23a mediates a loss of expression in the RAF kinase inhibitor protein RKIP. |
| Hatzl S, Geiger O, Kuepper MK, Caraffini V, Seime T, Furlan T, Nussbaumer E, Wieser R, Pichler M, Scheideler M, Nowek K, Lavrencic M, Quenhenberger F, Wölfler A, Troppmair J, Sill H, Zebisch A |
| Cancer research. 2016 Apr 15. pii: 0008-5472.CAN-15-3049. doi: 10.1158/0008-5472.CAN-15-3049 |
| PMID: 27197200 |
| Beyond the BRAF(V)(600E) hotspot - Biology and clinical implications of rare BRAF gene mutations in melanoma patients. |
| Richtig G, Hoeller C, Kashofer K, Aigelsreiter A, Heinemann A, Kwong LN, Pichler M, Richtig E |
| The British journal of dermatology. 2017 Mar 9. doi: 10.1111/bjd.15436 |
| PMID: 28278349 |
| Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma. |
| Cătană CS, Pichler M, Giannelli G, Mader RM, Berindan-Neagoe I |
| Oncotarget. 2017 Feb 25. pii: 15706. doi: 10.18632/oncotarget.15706 |
| PMID: 28392501 |
| A flexible 12-channel transceiver array of transmission line resonators for 7 T MRI. |
| Hosseinnezhadian S, Frass-Kriegl R, Goluch-Roat S, Pichler M, Sieg J, Vít M, Poirier-Quinot M, Darrasse L, Moser E, Ginefri JC, Laistler E |
| Journal of magnetic resonance (San Diego, Calif. : 1997). 2018 Aug 31. pii: S1090-7807(18)30218-0. doi: 10.1016/j.jmr.2018.08.013 |
| PMID: 30205313 |
| Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study. |
| Richtig G, Hoeller C, Wolf M, Wolf I, Rainer BM, Schulter G, Richtig M, Grübler MR, Gappmayer A, Haidn T, Kofler J, Huegel R, Lange-Asschenfeldt B, Pichler M, Pilz S, Heinemann A, Richtig E |
| PloS one. 2018 Oct 1. doi: 10.1371/journal.pone.0204729. pii: PONE-D-18-09420 |
| PMID: 30273398 |
| Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope? |
| Pichler R, Compérat E, Klatte T, Pichler M, Loidl W, Lusuardi L, Schmidinger M |
| Cancers. 2019 Mar 25. pii: cancers11030422. doi: 10.3390/cancers11030422 |
| PMID: 30934624 |
| Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis. |
| Moik F, Riedl JM, Winder T, Terbuch A, Rossmann CH, Szkandera J, Bauernhofer T, Kasparek AK, Schaberl-Moser R, Reicher A, Prinz F, Pichler M, Stöger H, Stotz M, Gerger A, Posch F |
| Scientific reports. 2019 Apr 3. doi: 10.1038/s41598-019-42069-1. pii: 10.1038/s41598-019-42069-1 |
| PMID: 30944390 |
| Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models. |
| Smolle MA, Sande MV, Callegaro D, Wunder J, Hayes A, Leitner L, Bergovec M, Tunn PU, van Praag V, Fiocco M, Panotopoulos J, Willegger M, Windhager R, Dijkstra SPD, van Houdt WJ, Riedl JM, Stotz M, Gerger A, Pichler M, Stöger H, Liegl-Atzwanger B, Smolle J, Andreou D, Leithner A, Gronchi A, Haas RL, Szkandera J |
| Cancers. 2019 Dec 21. pii: cancers12010047. doi: 10.3390/cancers12010047 |
| PMID: 31877801 |
| Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia. |
| Berg JL, Perfler B, Hatzl S, Mayer MC, Wurm S, Uhl B, Reinisch A, Klymiuk I, Tierling S, Pregartner G, Bachmaier G, Berghold A, Geissler K, Pichler M, Hoefler G, Strobl H, Wölfler A, Sill H, Zebisch A |
| Clinical epigenetics. 2021 Jan 6. doi: 10.1186/s13148-020-00979-2. pii: 10.1186/s13148-020-00979-2 |
| PMID: 33407852 |
| Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis. |
| Riedl JM, Posch F, Horvath L, Gantschnigg A, Renneberg F, Schwarzenbacher E, Moik F, Barth DA, Rossmann CH, Stotz M, Schaberl-Moser R, Pichler M, Stöger H, Greil R, Djanani A, Schlick K, Gerger A |
| European journal of cancer (Oxford, England : 1990). 2021 May 2. pii: S0959-8049(21)00207-0. doi: 10.1016/j.ejca.2021.03.040 |
| PMID: 33951545 |
| Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1. |
| Pichler M, Steyrer J |
| ESMO open. 2021 Jun 24. pii: S2059-7029(21)00159-9. doi: 10.1016/j.esmoop.2021.100198 |
| PMID: 34175674 |
| Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study. |
| Berger M, Thueringer A, Franz D, Dandachi N, Talakić E, Richtig G, Richtig E, Rohrer PM, Koch L, Wolf IH, Koch C, Rainer BM, Koeller M, Pichler M, Gerritsmann H, Kashofer K, Aigelsreiter A |
| Cancers. 2021 Jun 21. pii: cancers13123101. doi: 10.3390/cancers13123101 |
| PMID: 34205831 |
| Patterns of thromboembolism in patients with advanced pancreatic cancer undergoing 1st-line chemotherapy with FOLFIRINOX or Gemcitabine/nab-paclitaxel. |
| Riedl JM, Schwarzenbacher E, Moik F, Horvath L, Gantschnigg A, Renneberg F, Posch F, Barth DA, Stotz M, Pichler M, Hatzl S, Fandler-Höfler S, Gressenberger P, Gary T, Jost P, Greil R, Ay C, Djanani A, Gerger A, Schlick K |
| Thrombosis and haemostasis. 2021 Jul 12. doi: 10.1055/a-1548-4847 |
| PMID: 34255340 |
| Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. |
| Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R |
| The New England journal of medicine. doi: 10.1056/NEJMoa2104162 |
| PMID: 34320285 |
| Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria. |
| Tulchiner G, Staudacher N, Fritz J, Hackl M, Pichler M, Seles M, Shariat SF, D'Andrea D, Gust K, Albrecht W, Grubmüller K, Madersbacher S, Graf S, Lusuardi L, Augustin H, Berger A, Loidl W, Horninger W, Pichler R |
| Cancers. 2021 Oct 27. pii: cancers13215377. doi: 10.3390/cancers13215377 |
| PMID: 34771540 |
| Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study. |
| Dieckmann KP, Pokrivcak T, Geczi L, Niehaus D, Dralle-Filiz I, Matthies C, Dienes T, Zschäbitz S, Paffenholz P, Gschliesser T, Pichler R, Mego M, Bader P, Zengerling F, Heinzelbecker J, Krausewitz P, Krege S, Aurilio G, Aksoy C, Hentrich M, Seidel C, Törzsök P, Nestler T, Majewski M, Hiester A, Buchler T, Vallet S, Studentova H, Schönburg S, Niedersüß-Beke D, Ring J, Trenti E, Heidenreich A, Wülfing C, Isbarn H, Pichlmeier U, Pichler M |
| Therapeutic advances in medical oncology. 2022 Mar 31. doi: 10.1177/17588359221086813. pii: 10.1177_17588359221086813. pmc: PMC8977693 |
| PMID: 35386956 |
| Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells. |
| Uhl B, Prochazka KT, Pansy K, Wenzl K, Strobl J, Baumgartner C, Szmyra MM, Waha JE, Wolf A, Tomazic PV, Steinbauer E, Steinwender M, Friedl S, Weniger M, Küppers R, Pichler M, Greinix HT, Stary G, Ramsay AG, Apollonio B, Feichtinger J, Beham-Schmid C, Neumeister P, Deutsch AJ |
| International journal of molecular sciences. 2022 Jul 17. pii: ijms23147874. doi: 10.3390/ijms23147874 |
| PMID: 35887224 |
| 170 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9 › » |
Seite 1 / 9
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
